Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uterine Cervical Neoplasms × Ifosfamide × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 42 Lymphoma 31 Lymphoma, Large B-Cell, Diffuse 27 Osteosarcoma 20 Lymphoma, Non-Hodgkin 18 Hodgkin Disease 17 Testicular Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Ovarian Neoplasms 11 Burkitt Lymphoma 11 Testicular Germ Cell Tumor 10 Neuroectodermal Tumors, Primitive, Peripheral 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Follicular 8 Teratoma 7 Recurrence 7 Lymphoma, Large-Cell, Anaplastic 7 Leukemia 7 Central Nervous System Neoplasms 7 Neuroblastoma 6 Lymphoma, Mantle-Cell 6 Lymphoma, B-Cell 6 Breast Neoplasms 6 Seminoma 5 Neoplasms, Germ Cell and Embryonal 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Endodermal Sinus Tumor 5 Carcinoma, Non-Small-Cell Lung 5

Interventions

Cisplatin 85 Radiotherapy 45 Brachytherapy 35 Carboplatin 29 Paclitaxel 26 Surveys and Questionnaires 24 pembrolizumab 16 Radiation 16 Magnetic Resonance Spectroscopy 15 Colposcopy 15 Blood Specimen Collection 15 Methods 13 Bevacizumab 13 Drug Therapy 12 Papanicolaou Test 11 Biopsy 11 toripalimab 10 Topotecan 10 Gemcitabine 10 Early Intervention, Educational 10 Radiotherapy, Intensity-Modulated 9 Mass Screening 9 Docetaxel 9 camrelizumab 8 Patient Navigation 8 Papillomavirus Vaccines 8 Educational Status 8 Conization 8 Chemoradiotherapy 8 Nivolumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02422563 2015-04-21

NACOPRAD

Charite University, Berlin, Germany

Phase 3 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡